These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30264629)

  • 1. Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data.
    Wegener D; Zips D; Thorwarth D; Weiß J; Othman AE; Grosse U; Notohamiprodjo M; Nikolaou K; Müller AC
    Acta Oncol; 2019 Jan; 58(1):88-94. PubMed ID: 30264629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
    Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
    Pathmanathan AU; Schmidt MA; Brand DH; Kousi E; van As NJ; Tree AC
    J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
    Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK
    Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
    Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
    Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
    Tanaka O; Komeda H; Iida T; Tamaki M; Seike K; Kato D; Hirose S; Kawaguchi D; Yokoyama T
    Radiol Med; 2017 Mar; 122(3):204-207. PubMed ID: 27981486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
    Ghose S; Mitra J; Rivest-Hénault D; Fazlollahi A; Stanwell P; Pichler P; Sun J; Fripp J; Greer PB; Dowling JA
    Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of MRI visualization between linearly placed iron-containing and non-iron-containing fiducial markers for prostate radiotherapy.
    Tanaka O; Komeda H; Tamaki M; Seike K; Fujimoto S; Yama E; Hirose S; Matsuo M
    Br J Radiol; 2018 Feb; 91(1082):20170612. PubMed ID: 29120662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-to-end validation of fiducial tracking accuracy in robotic radiosurgery using MRI-only simulation imaging.
    Singhrao K; Zubair M; Nano T; Scholey JE; Descovich M
    Med Phys; 2024 Jan; 51(1):31-41. PubMed ID: 38055419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
    Jonsson JH; Garpebring A; Karlsson MG; Nyholm T
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1612-8. PubMed ID: 21477942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy.
    Pathmanathan AU; McNair HA; Schmidt MA; Brand DH; Delacroix L; Eccles CL; Gordon A; Herbert T; van As NJ; Huddart RA; Tree AC
    Br J Radiol; 2019 Mar; 92(1095):20180948. PubMed ID: 30676772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer.
    van den Ende RPJ; Rigter LS; Kerkhof EM; van Persijn van Meerten EL; Rijkmans EC; Lambregts DMJ; van Triest B; van Leerdam ME; Staring M; Marijnen CAM; van der Heide UA
    Radiother Oncol; 2019 Mar; 132():93-99. PubMed ID: 30825976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers.
    Goudschaal K; Beeksma F; Boon M; Bijveld M; Visser J; Hinnen K; van Kesteren Z
    Radiat Oncol; 2021 Feb; 16(1):37. PubMed ID: 33608008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate.
    Roberson PL; McLaughlin PW; Narayana V; Troyer S; Hixson GV; Kessler ML
    Med Phys; 2005 Feb; 32(2):473-82. PubMed ID: 15789594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy.
    Zhong H; Wen N; Gordon JJ; Elshaikh MA; Movsas B; Chetty IJ
    Phys Med Biol; 2015 Apr; 60(7):2837-51. PubMed ID: 25775937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
    Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
    Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression and statistical shape model based substitute CT generation for MRI alone external beam radiation therapy from standard clinical MRI sequences.
    Ghose S; Greer PB; Sun J; Pichler P; Rivest-Henault D; Mitra J; Richardson H; Wratten C; Martin J; Arm J; Best L; Dowling JA
    Phys Med Biol; 2017 Oct; 62(22):8566-8580. PubMed ID: 28976369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.
    Tanaka O; Komeda H; Hirose S; Taniguchi T; Ono K; Matsuo M
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e405-e411. PubMed ID: 29193796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative evaluation of fiducial markers for radiotherapy imaging.
    Chan MF; Cohen GN; Deasy JO
    Technol Cancer Res Treat; 2015 Jun; 14(3):298-304. PubMed ID: 25230715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.